"Nuclear medicine stubs" generally refer to small pieces of material or samples used in nuclear medicine procedures, typically involving radiopharmaceuticals. These stubs could be related to various applications, such as: 1. **Calibration Sources**: Small radioactive sources used to calibrate radiation detection equipment in nuclear medicine to ensure accurate measurements during imaging or dosing procedures.
90Y-DOTA-biotin is a radiopharmaceutical compound that combines the radioactive isotope Yttrium-90 (90Y) with a chelating agent known as DOTA (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) and biotin.
The American Board of Science in Nuclear Medicine (ABSNM) is a professional organization that focuses on certifying individuals in the field of nuclear medicine. Established to promote the highest standards of practice in nuclear medicine, the ABSNM offers credentialing for professionals who meet specific educational and experience requirements. Certification by the ABSNM indicates that an individual has demonstrated a certain level of expertise and knowledge in nuclear medicine, which can include areas such as diagnostic imaging, radiation safety, and therapeutic procedures.
Bone-seeking radioisotopes are radioactive isotopes that have an affinity for bone tissue, allowing them to accumulate in areas of bone, particularly those that are undergoing changes such as growth, repair, or disease processes. These isotopes are commonly used in medical applications, particularly in the treatment and diagnosis of certain conditions.
Cardiac PET (Positron Emission Tomography) is a type of imaging technique that provides detailed information about the functioning of the heart. It uses positron-emitting radiotracers, which are generally injected into the bloodstream, to visualize and assess various cardiac parameters.
The Committee on the Biological Effects of Ionizing Radiation (BEIR) is a group that operates under the National Academy of Sciences in the United States. Established to assess and report on the biological effects of ionizing radiation, the committee primarily focuses on the health risks associated with exposure to various types of ionizing radiation, including gamma rays, X-rays, and particle radiation.
Desmethoxyfallypride, often abbreviated as DMFP, is a chemical compound that is classified as a research chemical. It is a derivative of fallypride, which is an antipsychotic drug that primarily acts as a dopamine receptor antagonist. DMFP has been investigated for its potential effects on the dopamine system and may be studied in the context of neuropharmacology.
A dose profile typically refers to the distribution of a certain quantity (such as radiation, medication, or other substances) across a specific area, volume, or population over time. The term can apply in various fields, including: 1. **Medicine and Pharmacology**: In this context, a dose profile represents how a drug is administered to a patient over time, detailing factors like the amount of the drug given, the timing of doses, and the resulting plasma concentration levels in the body.
Emission computed tomography (ECT) is a type of imaging technique used in medical diagnostics to visualize the distribution of radioactive materials in the body. It works by detecting the gamma rays emitted from a radiotracer that has been administered to the patient. There are two main types of ECT: Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT).
Fallypride is a radiolabeled compound used in positron emission tomography (PET) imaging to study the dopamine D2 receptor in the brain. Its complete nomenclature is [(18)F]fallypride, which means it is labeled with the radioactive isotope fluorine-18.
The Gordon Center for Medical Imaging is an institution dedicated to advancing the field of medical imaging through research, education, and technology development. Located at the Massachusetts General Hospital (MGH) and affiliated with Harvard Medical School, the center focuses on various aspects of imaging technologies, including their application in diagnosing and treating medical conditions. The center often engages in projects related to the development of new imaging techniques, enhancing existing technologies, and improving patient care through innovative research.
The Imaging and Radiation Oncology Core (IROC) typically refers to a collaborative research and support infrastructure focused on advancing the fields of imaging and radiation oncology. It is often associated with clinical trials and research initiatives aimed at improving the effectiveness and safety of radiation therapy treatments for cancer patients. IROC facilities usually provide: 1. **Quality Assurance**: Ensuring that imaging and radiation delivery systems are functioning properly and delivering the expected doses to the targeted areas with minimal effects on surrounding healthy tissue.
Immunoscintigraphy is a medical imaging technique that utilizes radiolabeled antibodies or antibody fragments to visualize specific tissues or tumors within the body. It combines the principles of immunology and scintigraphy, which is a form of nuclear medicine imaging. In immunoscintigraphy, the antibodies used are typically designed to target specific antigens that are uniquely expressed or overexpressed on the surface of certain cancer cells or other tissues of interest.
Indium (111In) altumomab pentetate, commonly referred to as Indium-111-penetreotide or by its brand names such as OctreoScan, is a radiopharmaceutical used for medical imaging, particularly in the detection of neuroendocrine tumors. ### Key Components: - **Indium-111**: This is a radioactive isotope of indium used as a tracer in nuclear medicine. It emits gamma rays, which can be detected by imaging devices.
Indium (111In) capromab pendetide is a radiopharmaceutical used primarily in the medical imaging and diagnosis of prostate cancer. It is a monoclonal antibody that targets prostate-specific membrane antigen (PSMA), which is often overexpressed in prostate cancer cells.
Indium-111 (111In) imciromab is a radiolabeled monoclonal antibody used in nuclear medicine, specifically for imaging purposes. Imciromab is a humanized monoclonal antibody that targets the CD20 antigen, which is commonly expressed on the surface of B-cell lymphocytes, including malignant B-cells found in certain types of lymphomas and leukemias.
Indium (111In) satumomab pendetide is a radiopharmaceutical used primarily in the imaging of certain types of cancer, particularly those related to the detection of colorectal cancer. Here's a breakdown of its components: - **Indium-111 (111In)**: A radioactive isotope of indium, which is used in a variety of diagnostic imaging procedures due to its ability to emit gamma radiation.
The Institute of Nuclear Medicine & Allied Sciences (INMAS) is a research and educational institution in India that focuses on the field of nuclear medicine and its applications in healthcare, particularly in diagnosis and therapy. It is associated with the Defence Research and Development Organisation (DRDO) and is often involved in research related to the use of nuclear techniques in medical imaging, radiation therapy, and other health-related applications.
Iodine-131 derlotuximab biotin is a radiopharmaceutical that combines a targeted antibody with a radioactive isotope of iodine. The "131" in iodine-131 refers to its atomic mass, and it is commonly used in medical applications for its radioactive properties.
Iodobenzamide is a chemical compound that belongs to the class of benzamide derivatives. It is primarily recognized for its use in nuclear medicine and diagnostic imaging, particularly in scintigraphy, where it functions as a radiotracer. The compound is often labeled with iodine-123, allowing it to be used in imaging studies of the pancreas to assess conditions such as pancreatic tumors or to evaluate pancreatic function.
Iodocholesterol is a radiolabeled compound derived from cholesterol, where one or more iodine atoms have been substituted into the cholesterol structure. It is primarily used in medical imaging, particularly in the context of nuclear medicine. One of the most notable uses of iodocholesterol is in the diagnosis of various conditions affecting the adrenal glands, such as tumors.
Iodopindolol is a beta-adrenergic antagonist, also known as a beta-blocker. It is primarily used in the field of ophthalmology for the treatment of conditions such as glaucoma and elevated intraocular pressure. Iodopindolol works by reducing the production of aqueous humor in the eye, thereby helping to lower intraocular pressure.
Isocenter is a term commonly used in the fields of radiation therapy and medical imaging. It refers to a specific point in three-dimensional space that serves as the focal point for various types of radiation beams during treatment. In radiation therapy, the isocenter is the point around which the radiation beams are directed for the treatment of tumors. It is critical for ensuring that the targeted area receives the prescribed dose of radiation while minimizing exposure to surrounding healthy tissues.
The Japan Radioisotope Association (JRIA) is an organization in Japan that focuses on the promotion and advancement of radioisotope technology and its applications in various fields, including medicine, industry, and research. The JRIA plays a key role in supporting the safe and effective use of radioisotopes, providing information, education, and regulatory guidance to stakeholders.
Nuclear Medicine Communications is a scientific journal that focuses on the field of nuclear medicine, which involves the use of radioactive materials for diagnosis and treatment of diseases. The journal publishes research articles, reviews, and clinical studies related to the applications of nuclear medicine techniques, including but not limited to, imaging technologies (like PET and SPECT), therapeutic applications, dosimetry, radiopharmaceuticals, and the development of new technologies and methods in nuclear medicine.
PET response criteria in solid tumors refer to standardized guidelines used to interpret the results of positron emission tomography (PET) scans in the context of cancer treatment response. One of the most widely recognized sets of criteria is the Deauville criteria, which is specific for evaluating treatment response in lymphoma but can also be adapted for other solid tumors.
Plaque radiotherapy is a form of localized radiation treatment primarily used to treat certain types of eye cancer, particularly uveal melanoma, which is a type of melanoma that occurs in the eye. This treatment involves the use of a small, radioactive "plaque" that is surgically placed on the surface of the eye, directly over the tumor.
Plesiotherapy is a form of treatment that involves the use of plethysmography, which is a technique for measuring changes in volume within an organ or whole body, often related to the movement of fluids or air. This technique is often used in various medical fields to assess vascular function, respiratory health, or the general circulatory system. Plethysmography can be applied in different contexts, such as measuring blood flow in limbs, evaluating lung function, or assessing body composition.
Radioimmunodetection (RID) is a diagnostic technique that combines the principles of radioimmunology and imaging to identify and localize specific antigens in tissues or cells using radiolabeled antibodies. This method is primarily used in the field of oncology to detect cancerous tissues based on the presence of specific tumor markers or antigens. In RID, antibodies that are specific to the target antigen are labeled with a radioactive isotope.
Technetium (99mTc) etarfolatide is a radiopharmaceutical used as a diagnostic imaging agent in medicine, particularly in the field of oncology. It is specifically designed for molecular imaging to assess folate receptor expression in tumors.
Technetium (99mTc) votumumab is a radiolabeled monoclonal antibody used in medical imaging, particularly in the context of nuclear medicine for the diagnostic assessment of certain cancers.
A well counter is a specialized instrument used primarily in the field of nuclear medicine and radiation detection to measure the activity of radioactive samples. It is particularly effective in measuring low levels of radioactivity, making it essential for assays of radiopharmaceuticals and other small samples. The basic components of a well counter include: 1. **Detection Chamber**: The well, typically made of a scintillation material or a Geiger-Müller tube, is designed to hold the sample.
Yttrium (90Y) clivatuzumab tetraxetan is a radiolabeled monoclonal antibody that is used in targeted radiation therapy, specifically for the treatment of certain types of cancer. Here's a breakdown of its components: 1. **Yttrium-90 (90Y)**: This is a radioactive isotope of yttrium. It emits beta radiation, which can be used to destroy cancer cells in targeted therapy.
Yttrium (90Y) tacatuzumab tetraxetan is a radiopharmaceutical used in targeted radiotherapy, particularly for the treatment of certain types of cancers. In this compound: - **Yttrium-90 (90Y)**: This is a radioactive isotope of yttrium that emits beta particles, which can destroy cancer cells. Its radioactive properties make it effective for therapeutic purposes.
Articles by others on the same topic
There are currently no matching articles.